BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston
Ultragenyx at BPI 2026
Sep 22–25, 2026 Boston, MA ~3k attendees Website
Ultragenyx takes part in 3 sessions at BPI 2026 in Boston. Its sessions focus on AAV gene therapy manufacturing and the route to approval. One sets out a cell bank characterization and qualification strategy for AAV producer cell lines.
| Organization | BPI 2026 Attendance |
|---|---|
Ultragenyx Novato, California | |
Develops and commercializes therapies for rare and ultra-rare genetic diseases, including AAV gene therapies. | Talk Thu Sep 24 12:00pm–12:30pm Talk Thu Sep 24 4:30pm–5:30pm Panel Fri Sep 25 9:00am–10:00am |
Find decision makers at Ultragenyx
Tell us what you sell and we’ll find the people at Ultragenyx most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction